Why the study?
The study aimed to evaluate the effects of grape seed proanthocyanidin extract on blood pressure and vascular endothelial function in middle-aged adults with prehypertension.
Does grape seed proanthocyanidin extract improve blood pressure and vascular endothelial function in middle-aged Japanese adults with prehypertension?
Does grape seed proanthocyanidin extract improve blood pressure and vascular endothelial function in middle-aged Japanese adults with prehypertension?
High-dose grape seed proanthocyanidin extract (400 mg/day) significantly reduced systolic blood pressure and improved vascular elasticity parameters in middle-aged adults with prehypertension over 12 weeks.
May lower SBP in prehypertension; extends polyphenol evidence while leaving FMD effects unresolved.
This study aimed to investigate the effects of grape seed proanthocyanidin extract (GSPE) on blood pressure and vascular endothelial function in middle-aged Japanese adults with prehypertension. We conducted a randomized, double-blind, placebo-controlled study on 6 men and 24 women aged 40–64 years old. The participants were randomized to receive tablets containing either low-dose (200 mg/day) or high-dose (400 mg/day) GSPE, or placebo, for 12 weeks. Systolic and diastolic blood pressures (SBP and DBP, respectively), brachial flow-mediated dilation (FMD), and other cardiovascular parameters were measured before and after 4, 8, and 12 weeks of treatment. The mean SBP in the high-dose group significantly decreased by 13 mmHg after 12 weeks (P = 0.028), although FMD did not change. In an ad hoc analysis of non-smoking participants (n = 21), the mean SBP, DBP, stiffness parameter β, distensibility, incremental elastic modulus (Einc), and pulse wave velocity (PWV) also significantly improved in the high-dose group after 12 weeks. Changes in Einc and PWV from baseline to 12 weeks were significantly greater in the high-dose group than in the placebo group (Einc, P = 0.023; PWV, P = 0.03). GSPE consumption could help maintain vascular elasticity and normal blood pressure in this population.
No takes yet. Share an insight, caveat, or question.
Odai et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: